Lannett Company, Inc.  

(Public, NYSE:LCI)   Watch this stock  
Find more results for Cody Smith
55.39
May 22 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range     -
52 week 33.51 - 72.44
Open     -
Vol / Avg. 0.00/988,790.00
Mkt cap 2.01B
P/E 14.72
Div/yield     -
EPS 3.76
Shares 36.24M
Beta 1.47
Inst. own 64%
May 6, 2015
Q3 2015 Lannett Company Inc Earnings Call
May 6, 2015
Q3 2015 Lannett Company Inc Earnings Release
Apr 14, 2015
Lannett Company Inc at Needham Healthcare Conference
Mar 9, 2015
Lannett Company Inc at ROTH Conference
Feb 24, 2015
Lannett Company Inc at RBC Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 36.50% 20.88%
Operating margin 54.63% 32.18%
EBITD margin - 34.37%
Return on average assets 32.80% 22.39%
Return on average equity 36.05% 27.00%
Employees 399 -
CDP Score - -

Address

9000 State Rd
PHILADELPHIA, PA 19136-1615
United States - Map
+1-215-3339000 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Lannett Company, Inc. develops, manufactures, packages, markets and distributes solid oral (tablets and capsules), extended release, topical and oral solution finished dosage forms of drugs. The Company also manufactures active pharmaceutical ingredients through its Cody Laboratories, Inc. (Cody Labs) subsidiary. The Company operates pharmaceutical manufacturing plants in Philadelphia, Pennsylvania and Cody, Wyoming. Customers of the Company’s pharmaceutical products include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, Governmental entities and health maintenance organizations. The Company’s products include Levothyroxine Sodium tablets, Digoxin tablets, Butalbital, Cocaine Topical Solution and Morphine Sulfate Oral Solution.

Officers and directors

Jeffrey Farber Chairman of the Board
Age: 54
Bio & Compensation  - Reuters
Michael J. Bogda President
Age: 53
Bio & Compensation  - Reuters
Arthur P. Bedrosian J.D. Chief Executive Officer, Director
Age: 69
Bio & Compensation  - Reuters
Martin P. Galvan CPA, Chief Financial Officer, Vice President - Finance, Treasurer
Age: 62
Bio & Compensation  - Reuters
William F. Schreck Chief Operating Officer
Age: 66
Bio & Compensation  - Reuters
Robert Ehlinger Vice President - Logistics, Chief Information Officer
Age: 57
Bio & Compensation  - Reuters
Kevin R. Smith Vice President - Sales and Marketing
Age: 54
Bio & Compensation  - Reuters
William R. Farber Ph.D. Chairman Emeritus
Age: 83
Bio & Compensation  - Reuters
David Drabik Independent Director
Age: 46
Bio & Compensation  - Reuters
James M. Maher Independent Director
Age: 62
Bio & Compensation  - Reuters